Clinical characteristics and outcomes of autoimmune pancreatitis based on serum immunoglobulin G4 levels: A single-center, retrospective cohort study.

Autoimmune pancreatitis Immune System, Immunoglobulin A Immunoglobulin G Outcomes Relapse

Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
21 Dec 2023
Historique:
received: 22 09 2023
revised: 10 11 2023
accepted: 21 11 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: ppublish

Résumé

Autoimmune pancreatitis (AIP) is a complex, poorly understood disease gaining increasing attention. "Clinical Characteristics and Outcome of AIP Based on Serum IgG4 levels," investigated AIP with a focus on serum immunoglobulin (Ig) G4 levels. The 213 patients with AIP were classified according to serum IgG4 levels: Abnormal (elevated) and normal. Patients with higher IgG4 levels exhibited a more active immune system and increased relapse rates. Beyond IgG4, the IgA levels and age independently contributed to relapse risk, guiding risk assessment and tailored treatments for better outcomes. However, limitations persist, such as no IgA correlation with IgG4 levels, absent data on autoantibody-positive AIP cases critical for Asian diagnostic criteria, and unexplored relapse rates in high serum IgG AIP by subtype. Genetic factors and family histories were not addressed. As the understanding and referral of seronegative AIPs increase, there's a growing need for commercially available, highly sensitive, and specific autoantibodies to aid in diagnosing individuals with low or absent serum IgG4 levels.

Identifiants

pubmed: 38186685
doi: 10.3748/wjg.v29.i47.6161
pmc: PMC10768407
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6161-6164

Informations de copyright

©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: All authors declare no conflict of interest.

Auteurs

Fouad Jaber (F)

Department of Internal Medicine, University of Missouri-Kansas City, Kansas, MO 64108, United States. fouad.jaber.md@gmail.com.

Khaled Elfert (K)

Department of Internal Medicine, SBH Health System, New York, NY 10457, United States.

Saqr Alsakarneh (S)

Department of Internal Medicine, University of Missouri-Kansas City, Kansas, MO 64108, United States.

Azizullah Beran (A)

Department of Gastroenterology, Indiana University, 420 University Blvd, Indianapolis, IN 46202, United States.

Mohammed Jaber (M)

Department of Medical Education, Al Azhar University School of Medicine, Gaza P.O.Box 108, Palestine.

Manesh Kumar Gangwani (MK)

Department of Internal Medicine, The University of Toledo, Toledo, OH 43606, United States.

Yazan Abboud (Y)

Department of Internal Medicine, Rutgers New Jersey Medical School, Newar, NJ 57873, United States.

Classifications MeSH